JUVENILE PSORIATIC ARTHRITIS
Clinical trials for JUVENILE PSORIATIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new JUVENILE PSORIATIC ARTHRITIS trials appear
Sign up with your email to follow new studies for JUVENILE PSORIATIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with psoriatic arthritis: drug combo under trial
Disease control OngoingThis study is testing two injectable drugs, ustekinumab and guselkumab, in 50 children with active juvenile psoriatic arthritis. The goal is to see how well the drugs work, how they move through the body, and if they are safe. Participants will receive one of the drugs and be mon…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for kids with arthritis: drug trial shows promise
Disease control OngoingThis study tests whether the drug ixekizumab is safe and effective for children with certain types of juvenile arthritis (enthesitis-related arthritis and juvenile psoriatic arthritis). About 101 children aged 2 to 17 years will receive either ixekizumab or the standard drug adal…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC